Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 30/05/2023

Debbie Rigby rounds up the latest in research news Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease Among patients with COPD without exacerbations in the previous year, adherence to once daily dual bronchodilator therapy (umeclidinium/vilanterol) was superior to twice daily ICS/LABA at 12 months. The finding was consistent

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘We need more pharmacists’

Hmmm…how could we possibly get more pharmacists to go rural…hmmm….oh wait! What’s that thing called again? You know…it starts with…

John Smith

What does the future look like for CWH/Sigma shareholders?

But doesn’t this change as they slowly cripple their competition? It’s the classic Walmart move. Walk in, kill the competition…

John Smith

What does the future look like for CWH/Sigma shareholders?

I’m not sure if I’m just cynical but Ponraj came across as incredibly naive in this article. He was surprised…

John Smith

‘Doctor of Pharmacy’ title announced

Will any of this lead to direct claiming from Medicare for our new doctors?

John Smith

Research Roundup

Previous Oral semaglutide as effective as injectable

Next Wesfarmers to ‘rationalise underperforming’ own Priceline stores; briefing

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Oral semaglutide as effective as injectable

Next Wesfarmers to ‘rationalise underperforming’ own Priceline stores; briefing

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.